Inactivation of enveloped viruses (VSy S¥V, and SHV-1) by surfactin lipopeptides was dependent on the hydrophobicity, i.e. the number of carbon atoms of the fatty acid, and on the charge of the peptide moiety as well as on the virus species. Surfactins with fatty acid chains of 13 carbon atoms showed very low antiviral activity in comparison to C14 and C15 isoforms. C15 surfactin monomethyl ester also inactivated SFVwhich was resistant to the mixture of surfactin isoforms as produced by Bacillus subtilis. In contrast, the dimethyl ester showed no virus-inactivation capacity. Disintegration of viral structures as determined by electron microscopy after inactivation of VSVand SFVwas comparable to the liter reduction. The effect of the surfactin isoforms and methyl esters on erythrocyte hemolysis correlated with the virus-inactivation capacity. Surfactins with a fatty acid chain moiety of 15 carbon atoms and one negative charge showed the highest antiviral activity.
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Bioactive peptides with diverse structures and biological activities have been isolated from various microorganisms.1>2) Bacillus subtilis, a soil bacterium, produces nonribosomally the cyclic lipopeptide antibiotic surfactin2) showing biosurfactant, 3?4) antimicrobial,5'6^antimycoplasmatic,7)
antiviral,8~10) antitumor1 1} and hemolytic3' 5) properties. Surfactin consists of an anionic seven-memberedpeptide
and a hydrophobic /J-hydroxy fatty acid varying in length and branching of its carbon chain (for a review of these isoforms see ref. 12). The fatty acid is bound via its carboxyl group to the TV-terminal glutamic acid and the lipopeptide ring is closed by lactone formation between the /?-hydroxy group of the fatty acid and the carboxyl group of the C-terminal leucine. The numberof carbon atoms of its /J-hydroxy fatty acid varies from 13 to 15; the main lipid component is 3-hydroxy-1 3-methylmyristic acid. 13 '14) Several authors8^10) have shown antiviral properties of surfactin, especially against enveloped viruses.10) All these studies have been performed with the natural mixture of Surfactin monomethyland dimethyl esters were synthesized by treating surfactin with methanolic HC1 for 1-3 days, followed by isolation as above, using a gradient of 35-50% B in 0-30 minutes. Twosurfactin monomethyl esters containing fatty acids with 14 and 15 C atoms and one C15 surfactin dimethyl ester were isolated. C15 indicates the numberof carbon atoms of the fatty acid chain. Then they were immediately titrated. Initial titer and the spontaneous inactivation of virus in medium were determined in parallel experiments. For all inactivation studies using isoforms and derivatives, the surfactin mixture was run as a control in parallel. Virus titers JULY 1999 were determined in a standard assay using a 96-well microtiter plate essentially as described.10) Briefly, 100 /il of a cell suspension (5Xl04~5Xl05cells/ml, depending on the virus) were placed in each well. The virus solutions were serially diluted 1 : 3 in DMEMsupplemented with 5% FCS. Aliquots of 100 ji\ per dilution step were added to each of 8 wells of the microtiter plate. After 2-4 days of incubation the cultures were evaluated microscopically. The virus titer (TCID50/ml) was calculated according to Spearman and Karber. 17) Hemolysis of HumanErythrocytes For hemolysis experiments, 1.4X 107 freshly prepared human erythrocytes in 0.1 ml 0.15m NaCl were added to 0.9 ml of serial dilutions of the various surfactin isoforms or derivatives. After incubation for 30minutes in a water bath at 37°C, the optical density of the supernatant after centrifugation (15,000Xg, 15 minutes) was determined at 540nm in comparison to the control without lipopeptide added (no lysis). The complete lysis value obtained by adding 0.1 ml erythrocytes to 0.9ml of distilled water was set as 100%.
Electron Microscopy
Virus was propagated in BHK-21cells in DMEM supplemented with 3% FCS. SFVand VSVwere harvested 31 hours and 23 hours past infection, respectively, the supernatant cleared from debris by centrifugation (20 minutes, 200 X g). Virus-containing supernatants were incubated with surfactin or C15 surfactin monomethyl ester (40jllm for SFY 33 jiu for VSV) for 1 hour at room temperature. Controls without surfactin were run in parallel. Incubation was stopped by adding 10ml of cold 0.2m HEPES buffer (pH 7.2), and the mixture ultracentrifuged through a layer of 4ml 25% sucrose in PBS (Beckman Optima, rotor SW28; 2 hours, 100,000X0 at 4°C). Pellets were resuspended in 0.5 ml HEPESbuffer and aliquots used for determination of infectious virus. After negative staining with 2% phosphotungstic acid (PTA) or uranyl acetate (UAC) on Pioloform-(Wacker Chemie-Mimchen)-coated and carbon stabilized 300 mesh grids, the specimens were examined by electron microscopy (Zeiss EM902, 80 kV). First, the dependence of antiviral activity on the fatty acid chain length of surfactin was investigated (Fig. 1) . SHV-1was inactivated by all three surfactin isoforms. The C14 and C15 isoforms showed an inactivation capacity comparable to that of the surfactin mixture (reduction factor 104), the C13 isoform was less active with a reduction factor of 400 after 20 minutes. VSVshowed a pronounced dependence on the fatty acid chain length of surfactin. The surfactin mixture (reduction factor 4 X 1 05) and the C14 isoform showed comparable inactivation kinetics, the C1 5 species inactivated VSVmore efficiently (reduction factor 1.2X106), whereas in contrast to SHV-1 the C13 surfactin was inactive with an insignificant reduction factor of < 10. In earlier experiments no effect on the inactivation of SFVby the surfactin mixture had been found. This finding was extended by the investigation of the three isoforms which were also inactive (reduction factors < 1 0). On the other hand, we investigated the influence of esterification of surfactin on the antiviral capacity (Fig. 2) . The C14-and the C15 monomethyl ester inactivated SHV-1 615 and VSVat rates comparable to the surfactin mixture. In contrast to the unesterified surfactin mixture or the purified isoforms of surfactin the monomethyl esters showed a significant inactivation of SFV The C14 ester inactivated SFV with a reduction factor of 800 (compared to 8 with surfactin mixture). The C15 ester was even more effective against SFV with a reduction factor of 3.8X I04. The uncharged C 1 5 surfactin dimethyl ester was completely inactive against all three viruses.
To investigate the different effects of esterified and unesterified lipopeptides on the morphology of viruses, VSVand SFV were treated with the surfactin mixture and the C15 surfactin monomethyl ester. After sedimentation, the pellet was resuspended and the specimen negatively stained. In contrast to untreated controls of VSV(data not shown) and SFV (Fig. 3a) , surfactin caused a total destruction of VSV(data not shown), but had only a limited effect on the viral envelope and the capsid structure of SFV (Fig. 3b) . However, the C15 surfactin monomethyl ester caused an almost total disintegration of the SFVparticles O C14 monomethyl ester, A C15 monomethyl ester, + C15 dimethyl ester, aefsurfactin mixture.
and additionally a partial destruction of the nucleocapsid (Fig..3c) . These effects correlate with the biological activity determined by virus titration.
Hemolysis of Human Erythrocytes by Surfactin
Isoforms and Their Methyl Esters A rapid lysis of erythrocytes was observed with the surfactin mixture at 40 flu, which is the concentration used for virus-inactivation studies: After 5 minutes >80%of the erythrocytes were lysed. The concentration dependency of hemolysis with various surfactins was measured after 30 minutes at 37°C and the 50% effective dose (ED50) calculated ( Table 1 ).
The obtained results show a good correlation with the virus-inactivation studies. C13 surfactin had the lowest activity of the fatty acid chain isoforms. The hemolytic activity increased with their hydrophobicity.
Again, the C15 surfactin monomethyl ester showed the highest efficiency, while the diester was almost ineffective (2% hemolysis at 100 jiu for 30 minutes).
Discussion
The numberof carbon atoms of the fatty acid chain of surfactin is one of the important factors for virus inactivation by this lipopeptide. à¬13surfactins showed either no (VSV) or a lower activity (SHV-1) than the surfactin mixture. With increasing fatty acid hydrophobicity the virusinactivation capacity of the isoforms increased. For VSV the C1 5 surfactin showed the highest activity, i.e. reduction factor was six times higher compared to the surfactin mixture. Surfactin mixture, C14 and C15 isoforms induced similar reduction factors against SHV-1. None of the purified isoforms showed significant inactivation of SFV Comparing these results obtained with SFX VSV and SHV-1, which were grown on the same cells, specific differences in inactivation capacity of the surfactin isoforms For negative staining electron microscopy 2%PTAon carbonstabilized Cu-grids were used. Surfactin caused a moderate virus membrane and capsid damage of SFV(b), but treatment with C15 monomethyl ester showed a total destruction of the virus particles (c).
encoded glycoproteins.
The influence of the negative charges of the peptide moiety of surfactin was examined with monomethyland dimethyl ester derivatives. In contrast to the strong inactivation capacity of C15 surfactin against VSV and SHV-1, the uncharged C15 dimethyl ester was completely ineffective. The activity of the two surfactin monomethyl ester isoforms against VSVand SHV-1 was comparable to that of the surfactin mixture. In contrast to all other surfactin isoforms, the two compounds, especially the C15 monomethyl ester, showed a high inactivation capacity against SFV Differences in inactivation kinetics of SFV with single esterified and unesterified surfactin isoforms could be explained by the structure of the virion. The nucleocapsid of SFV is enveloped by a lipid bilayer, which contains the viral spike proteins. In contrast to SHV-1and VSV, the During inactivation with the monomethyl ester the molecules seem to interact with the virus subunits inducing a loss of infectivity of SFV due to the disintegration of viral proteins and lipid bilayer. The effect of treating viruses with surfactin mixture or C15 surfactin monomethylester was visualized by electron microscopy. Destruction of virus particles ( Fig. 3b and 3c) is correlated with reduction of infectivity titers after treatment with lipopeptides. The sensitivity of humanerythrocytes to the lipopeptides correlates to some degree with the results obtained with virus inactivation.
Therefore, the determination of this effect can be used for preselection of active antiviral compoundsfor virus inactivation.
Summarizing the results, inactivation of enveloped viruses by surfactin lipopeptides depends on the hydrophobicity of the fatty acid moiety, on the charge of the peptide moiety as well as on the virus species. Higher numbers of carbon atoms in the fatty acid chain and one negative charge of the peptide ring result in more active compounds.
Therefore, addition of the lipopeptides to cell cultures used in laboratories and biotechnological production can be a useful tool for virus inactivation and protection against virus infection. Due to the hemolytic activity, the clinical application is limited to local treatment of viral infections or to the prevention of virus transmission.
